HuagongsheHuagongshe Chemistry Print Report · For research reference only
Hydrogen Bromide → Tofacitinib hydrobromide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Hydrogen Bromide | HCID 260 | — |
| Reactant | Tofacitinib | HCID 9926791 | — |
| Solvent | Acetone | HCID 180 | — |
| Product | Tofacitinib hydrobromide | HCID 131734730 | 100.6% |
Reaction Steps
An aqueous solution (48 wt %) of hydrogen bromide (3.44 g, 20.4 mmol) was added to a solution of tofacitinib free base (5.60 g, 17.9 mmol) in acetone (30 mL). The resulting oily suspension was stirred for 1 hour at 25° C. before acetone was removed in vacuo by rotary evaporation and the residual solid was dried under vacuum (8 torr) for 16 hours at 25° C. to yield 7.08 g of amorphous tofacitinib hydrobromide as a pale orange solid. 1H NMR analysis showed a residual acetone content of approximately 1.0 wt %.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09260438B2 |
| Source dataset | uspto-grants-2016_02 |
| ORD ID | ord-6a8d481a7455486aac01ed74da7fb4bd |
| Source note | uspto-grants-2016_02 |